The DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index, and 2 are not checked yet.
Liver fibrosis
Open accessAbstract
Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [2]
In the citing paper
“In more advanced disease stages, the ECM can replace functional liver parenchyma and thereby contribute to the development of liver cirrhosis, which is characterized by bridging fibrosis, regenerative nodules, and the loss of liver function [230].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · cites this paper as [230]
In the citing paper
“Two of the prototype cytokines responsible for the activation of HSCs during liver injury are the transforming growth factor-β (TGF-β) and the platelet-derived growth factor (PDGF).[3]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,171
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06038.x · Cited by 2,078
Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Flagged first, then by citations
Research works printed but not linked: 9
- Soyer, 1976, Surgery., 79, 601
- Otto, 1980, Adv. Exp. Med. Biol., 132, 509
- Wasser, 1999, Ann. Acad. Med. Singapore., 28, 109
- Brunt, 2004, Semin. Liver Dis., 24, 3
- Phillips, 2004, J. Clin. Invest., 114, 438, 10.1172/jci200420997 · DOI
- Kmiec, 2001, Adv. Anat. Embryol. Cell Biol., 161, III–XIII, 1–151
- Thurman, 1998, Am. J. Physiol., 275, G605
- Wei, 2000, World J. Gastroenterol., 6, 540
- Tuncer, 2003, Exp. Toxicol. Pathol., 55, 159
Cited by
Sorted by citations
Items 701–800 of 1,040
Role of gamma-delta T cells in liver inflammation and fibrosis
Hammerich, L., & Tacke, F. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i2.107 · Cited by 93
García‐Monzón, C., Iacono, O. L., Mayoral, R., González‐Rodríguez, Á., Miquilena-Colina, M. E., Lozano-Rodríguez, T., García-Pozo, L., Vargas‐Castrillón, J., Casado, M., Boscá, L., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.021 · Cited by 94
Stiffness reconstruction methods for MR elastography
Fovargue, D., Nordsletten, D., & Sinkus, R. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3935 · Cited by 93
Tacke, F. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s27 · Cited by 92
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2018) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 93
Self-citationDong, Z., Li, S., Wang, X., Si, L., Ma, R., Bao, L., & Bo, A. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00249.2018 · Cited by 92
In vitro reversion of activated primary human hepatic stellate cells
Taghdouini, A. E., Najimi, M., Sancho‐Bru, P., Sokal, E. M., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 92
Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C†
Saadoun, D., Asselah, T., Resche‐Rigon, M., Charlotte, F., Bédossa, P., Valla, D. C., Pietté, J. C., Marcellin, P., & Cacoub, P. (2006) · Hepatology · doi:10.1002/hep.21190 · Cited by 92
Induced pluripotent stem cells and personalized medicine: current progress and future perspectives
Chun, Y. S., Byun, K., & Lee, B. (2011) · Anatomy & Cell Biology · doi:10.5115/acb.2011.44.4.245 · Cited by 92
Berres, M., Papen, S., Pauels, K., Schmitz, P., Zaldivar, M. M., Hellerbrand, C., Mueller, T., Berg, T., Weiskirchen, R., Trautwein, C., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.016 · Cited by 92
Shimamura, T., Fujisawa, T., Husain, S. R., Kioi, M., Nakajima, A., & Puri, R. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4656 · Cited by 92
Ding, R., Tian, K., Cao, Y., Bao, J., Wang, M., He, C., Yuanjia, H., Su, H., & Wan, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf502990n · Cited by 92
Hotair facilitates hepatic stellate cells activation and fibrogenesis in the liver
Bian, E., Wang, Y., Yang, Y., Wu, B., Xu, T., Meng, X., Huang, C. Z., Zhang, L., Lv, X., Xiong, Z., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.009 · Cited by 91
Prasad, B., Bhatt, D. K., Johnson, K., Chapa, R., Chu, X., Salphati, L., Xiao, G., Lee, C. G. L., Hop, C. E. C. A., Mathias, A. A., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.080523 · Cited by 91
LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
Yu, F., Geng, W., Dong, P., Huang, Z., & Zheng, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1068-x · Cited by 91
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Weston, C. J., Zimmermann, H. W., & Adams, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00893 · Cited by 92
PROLIDASE: A Review from Discovery to its Role in Health and Disease
Eni-Aganga, I., Lanaghan, Z. M., Balasubramaniam, M., Dash, C., & Pandhare, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.723003 · Cited by 91
Krawczyk, M. J., Grünhage, F., Zimmer, V., & Lammert, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.042 · Cited by 91
Stearic acid attenuates cholestasis-induced liver injury
Pan, P., Lin, S., Ou, Y., Chen, W., Chuang, Y., Yen, Y.-J., Liao, S., Raung, S., & Chen, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.119 · Cited by 91
Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by Bioconjugation
Zhu, L., & Mahato, R. I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100346n · Cited by 91
Tzankova, V., Aluani, D., Kondeva-Burdina, M., Yordanov, Y., Odzhakov, F., Apostolov, А., & Yoncheva, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.008 · Cited by 91
Faggioli, F., Palagano, E., Di Tommaso, L., Donadon, M., Marrella, V., Recordati, C., Mantero, S., Villa, A., Vezzoni, P., & Cassani, B. (2018) · Hepatology · doi:10.1002/hep.29636 · Cited by 90
DeZwaan-McCabe, D., Riordan, J. D., Arensdorf, A. M., Icardi, M. S., Dupuy, A. J., & Rutkowski, D. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003937 · Cited by 90
Liang, K., Hsu, C., Chang, M., Chen, Y., Lai, M., & Yeh, C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv547 · Cited by 90
FXR modulators for enterohepatic and metabolic diseases
Wang, H., He, Q., Wang, G., Xu, X., & Hao, H. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1527906 · Cited by 90
Regulatory T cells (Tregs) in liver fibrosis
Wu, K., Qian, Q., Zhou, J., Sun, D., Duan, Y., Zhu, X., Sartorius, K., & Lu, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01347-8 · Cited by 90
Matsuzaki, K. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1178-6 · Cited by 90
Ohe, H., Uchida, Y., Yoshizawa, A., Hirao, H., Taniguchi, M., Maruya, E., Yurugi, K., Hishida, R., Maekawa, T., Üemoto, S., et al. (2014) · Transplantation · doi:10.1097/tp.0000000000000185 · Cited by 90
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis
Mueller, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10482 · Cited by 89
Collagen crosslinking: effect on structure, mechanics and fibrosis progression
Kong, W., Lyu, C., Liao, H., & Du, Y. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac2b79 · Cited by 89
Fang, L., Zhan, S., Huang, C. Z., Cheng, X., Lv, X., Si, H., & Li, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.009 · Cited by 89
Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
Moles, A., Tarrats, N., Morales, A., Domínguez, M., Bataller, R. A., Caballería, J., García‐Ruiz, C., Fernández-Checa, J. C., & Marı́, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091257 · Cited by 89
Self-citationMarquardt, J. U., Seo, D., Gómez-Quiroz, L. E., Uchida, K., Gillen, M. C., Kitade, M., Kaposi-Novák, P., Conner, E. A., Factor, V. M., & Thorgeirsson, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.012 · Cited by 89
Bacigalupo, M. L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i47.8831 · Cited by 89
Chronic Pancreatitis: Recent Advances and Ongoing Challenges
Ahmad, S. A., Wray, C. J., Rilo, H., Choe, K. A., Gelrud, A., Howington, J. A., Lowry, A. M., & Matthews, J. B. (2006) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2005.12.005 · Cited by 89
Fibronectin expression is critical for liver fibrogenesis in vivo and in vitro
Liu, X., Liu, R., Hou, F., Cui, L., Li, C.-Y., Chi, C., Yi, E.-T., Wen, Y., & Yin, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5673 · Cited by 89
Ganai, A. A., & Husain, M. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.11.022 · Cited by 89
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
Hernández‐Aquino, E., Zarco, N., Casas‐Grajales, S., Ramos‐Tovar, E., Flores‐Beltrán, R. E., Arauz, J., Shibayama, M., Favari, L., Tsutsumi, V., Segovia, J., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4354 · Cited by 89
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis
Wu, X., Wu, X., Ma, Y., Shao, F., Tan, Y., Tan, T., Gu, L., Zhou, Y., Sun, B., Sun, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms13498 · Cited by 88
From the stomach to other organs:Helicobacter pyloriand the liver
Waluga, M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i18.2136 · Cited by 88
Zheng, D., Jiang, Y., Qu, C., Yuan, H., Hu, K., He, L., Chen, P., Li, J., Tu, M., Lin, L., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.002 · Cited by 88
Tang, M., Chen, Y., Li, B., Sugimoto, H., Yang, S., Yang, C., LeBleu, V. S., McAndrews, K. M., & Kalluri, R. (2021) · The FASEB Journal · doi:10.1096/fj.202002777rr · Cited by 88
The Impressive Anti-Inflammatory Activity of Cerium Oxide Nanoparticles: More than Redox?
Corsi, F., Tarquini, G. D., Urbani, M., Bejarano, I., Traversa, E., & Ghibelli, L. (2023) · Nanomaterials · doi:10.3390/nano13202803 · Cited by 88
Hypoxia induces the activation of human hepatic stellate cells LX‐2 through TGF‐β signaling pathway
Shi, Y., Fong, C., Zhang, Q., Cheung, P., Tzang, C., Wu, R. S. S., & Yang, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.12.010 · Cited by 88
Human antigen R contributes to hepatic stellate cell activation and liver fibrosis
Woodhoo, A., Iruarrizaga‐Lejarreta, M., Beraza, N., García‐Rodríguez, J. L., Embade, N., Fernández‐Ramos, D., Martínez-López, N., Juan, V. G., Arteta, B., Caballería, J., et al. (2012) · Hepatology · doi:10.1002/hep.25828 · Cited by 88
Jeng, J.-S., Tsai, J., Chuang, L.-Y., Ho, M., Lin, Z., Hsieh, M., Chen, S.-C., Chuang, W., Wang, L., Yu, M., et al. (2007) · Neoplasia · doi:10.1593/neo.07781 · Cited by 88
Matricellular Protein Periostin Contributes to Hepatic Inflammation and Fibrosis
Huang, Y., Liu, W., Xiao, H., Maitikabili, A., Lin, Q., Wu, T., Huang, Z., Liu, F., Luo, Q., & Ouyang, G. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.002 · Cited by 88
From MAFLD to hepatocellular carcinoma and everything in between
Bae, S. D. W., George, J., & Qiao, L. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002089 · Cited by 87
Toll-Like Receptors in Liver Disease
Petrášek, J., Csák, T., & Szabó, G. (2012) · Advances in clinical chemistry · doi:10.1016/b978-0-12-405211-6.00006-1 · Cited by 87
Developmental control of macrophage function
Bonnardel, J., & Guilliams, M. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.12.001 · Cited by 87
Nakano, Y., Kamiya, A., Sumiyoshi, H., Tsuruya, K., Kagawa, T., & Inagaki, Y. (2020) · Hepatology · doi:10.1002/hep.30965 · Cited by 86
Perumal, N., Perumal, M. K., Devaraj, H., & NiranjaliDevaraj, S. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.017 · Cited by 86
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 92
Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells
Shi, H., Dong, L., Dang, X., Liu, Y., Jiang, J., Wang, Y., Lu, X., & Guo, X. (2013) · Inflammation Research · doi:10.1007/s00011-013-0610-7 · Cited by 86
Lin, J., & Chen, A. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.20 · Cited by 86
Fleig, S. V., Choi, S. S., Yang, L., Jung, Y., Omenetti, A., VanDongen, H. M. A., Huang, J., Sicklick, J. K., & Diehl, A. M. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700689 · Cited by 86
Nevzorova, Y. A., Hu, W., Cubero, F. J., Haas, U., Freimuth, J., Tacke, F., Trautwein, C., & Liedtke, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.001 · Cited by 86
Toll-like receptors in the pathogenesis of pulmonary fibrosis
Karampitsakos, Τ., Woolard, T., Bouros, D. E., & Τzouvelekis, Α. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.045 · Cited by 86
Arauz, J., Galicia‐Moreno, M., Cortés‐Reynosa, P., Salazar, E. P., & Muriel, P. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2788 · Cited by 85
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
Natarajan, V., Harris, E. N., & Kidambi, S. (2017) · BioMed Research International · doi:10.1155/2017/4097205 · Cited by 85
Wang, K., Yang, X., Wu, Z.-J., Wang, H., Li, Q., Mei, H., You, R., & Zhang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00240 · Cited by 85
Noninvasive Biomarkers of Liver Fibrosis: An Overview
Fallatah, H. I. (2014) · Advances in Hepatology · doi:10.1155/2014/357287 · Cited by 85
Okabe, H., Beppu, T., Ueda, M., Hayashi, H., Ishiko, T., Masuda, T., Otao, R., Horlad, H., Mima, K., Miyake, K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27496 · Cited by 85
Ji, Y., Wang, T., Wei, Z., Lu, G.-X., Jiang, S., Xia, Y., & Dai, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.017 · Cited by 85
Lavallard, V., Bonnafous, S., Patouraux, S., Saint‐Paul, M., Rousseau, D., Anty, R., MARCHAND‐BRUSTEL, Y. L., Tran, A., & Gual, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017599 · Cited by 85
Tai, D., Tan, N., Xu, S., Kang, C. H., Chia, S. M., Cheng, C. L., Wee, A., Wei, C. L., Raja, A. M., Xiao, G., et al. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3183811 · Cited by 85
Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study
Sande, J., Verjee, S., Vinayak, S., Amersi, F. F., & Ghesani, M. V. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i1.38 · Cited by 85
Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
Wan, Y., McDaniel, K. M., Wu, N., Ramos‐Lorenzo, S., Glaser, T., Venter, J. K., Francis, H., Kennedy, L. L., Sato, K., Zhou, T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.027 · Cited by 85
Redundant Roles of Rpn10 and Rpn13 in Recognition of Ubiquitinated Proteins and Cellular Homeostasis
Hamazaki, J., Hirayama, S., & Murata, S. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005401 · Cited by 85
Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model
Saijou, E., Enomoto, Y., Matsuda, M., Yuet‐Yin Kok, C., Akira, S., Tanaka, M., & Miyajima, A. (2018) · Hepatology Communications · doi:10.1002/hep4.1178 · Cited by 84
Use of Electronic Noses for Diagnosis of Digestive and Respiratory Diseases through the Breath
Sánchez, C., Santos, J. P., & Lozano, J. (2019) · Biosensors · doi:10.3390/bios9010035 · Cited by 84
Rhodes, K. A., Andrew, E. M., Newton, D. J., Tramonti, D., & Carding, S. R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838354 · Cited by 84
MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7
Yu, F., Guo, Y. G., Chen, B., Dong, P., & Zheng, J. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.58 · Cited by 84
Fibrosis in Autoimmune and Cholestatic Liver Disease
Penz-Österreicher, M., Österreicher, C. H., & Trauner, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.001 · Cited by 84
Grzelak, C. A., Martelotto, L. G., Sigglekow, N. D., Patkunanathan, B., Ajami, K., Calabrò, S., Dwyer, B. J., Tirnitz‐Parker, J. E. E., Watkins, D. N., Warner, F. J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.012 · Cited by 84
Beneficial effect of quercetin on cholestatic liver injury
Lin, S., Wang, Y., Chen, W., Chuang, Y., Pan, P., & Chen, C. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.06.003 · Cited by 83
Grgurević, L., Christensen, G. L., Schulz, T. J., & Vukičević, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.12.009 · Cited by 84
Liang, D., Chen, H., Zhao, L., Zhang, W., Hu, J., Liu, Z., Zhong, P., Wang, W., Wang, J., & Liang, G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.016 · Cited by 83
Choi, S., Jeong, S., & Hwang, S. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.038 · Cited by 83
Adiponectin Agonist ADP355 Attenuates CCl4-Induced Liver Fibrosis in Mice
Kumar, P., Smith, T., Rahman, K., Thorn, N. E., & Anania, F. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110405 · Cited by 83
MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats
Tao, H., Huang, C., Yang, J., Ma, T., Bian, E., Zhang, L., Lv, X., Jin, Y. J., & Li, J. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.011 · Cited by 83
Ling, H., Roux, E., Hempel, D. M., Tao, J., Smith, M. M., Lonning, S. M., Zuk, A., ARBEENY, C. M., & Ledbetter, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054499 · Cited by 83
Qian, H., Deng, X., Huang, Z., Wei, J., Ding, C., Feng, R.-X., Zeng, X. Y., Chen, Y.-X., Ding, J., Qiu, L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.84 · Cited by 83
Tokunaga, Y., Osawa, Y., Ohtsuki, T., Hayashi, Y. K., Yamaji, K., Yamane, D., Hara, M., Munekata, K., Tsukiyama–Kohara, K., Hishima, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00282-w · Cited by 83
Forkel, M., Berglin, L., Kekäläinen, E., Carlsson, A., Svedin, E., Michaëlsson, J., Nagasawa, M., Erjefalt, J. S., Mori, M., Flodström‐Tullberg, M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646890 · Cited by 83
Czauderna, C., Castven, D., Mahn, F. L., & Marquardt, J. U. (2019) · Cancers · doi:10.3390/cancers11081053 · Cited by 83
Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis
Moreno, M., & Bataller, R. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.013 · Cited by 83
Self-citationAbramovitch, S., Sharvit, E., Weisman, Y., Bentov, A., Brazowski, E., Cohen, G., Volovelsky, O., & Reif, S. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2013 · Cited by 82
Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis
Magdaleno, F., Arriazu, E., de Galarreta, M. R., Chen, Y., Ge, X., de la Rosa, L. C., & Nieto, N. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.003 · Cited by 82
Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
Chen, H., Cai, J., Wang, J., Qiu, Y., Jiang, C., Wang, Y., Wang, Y., Yi, C., Lv, G., Pan, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.016 · Cited by 82
Chiang, D. J., Roychowdhury, S., Bush, K., McMullen, M. R., Pisano, S. G., Niese, K. A., Olman, M. A., Pritchard, M. T., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069114 · Cited by 82
Effect of Fuzheng Huayu formula and its actions against liver fibrosis
Liu, C., Hu, Y., Xu, L., Liu, C., & Liu, P. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-12 · Cited by 82
Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms
Gieling, R. G., Burt, A. D., & Mann, D. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.001 · Cited by 82
Zhang, B., Xu, D., Guo, Y., Ping, J., Chen, L., & Wang, H. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04819.x · Cited by 82
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis
Hsu, Y., Chiu, Y., Cheng, C., Wu, C., Lin, Y., & Huang, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04361.x · Cited by 82
Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis
Chen, X., Li, H.-D., Bu, F., Li, X., Chen, Y., Zhu, S., Wang, J., Chen, S., Sun, Y.-Y., Pan, X., et al. (2020) · Theranostics · doi:10.7150/thno.42423 · Cited by 81
Programmed cell death in hepatic fibrosis: current and perspectives
Lu, J.-L., Yu, C.-X., & Song, L.-J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01749-8 · Cited by 81
Sasaki, R., Yamasaki, K., Abiru, S., Komori, A., Nagaoka, S., Saeki, A., Hashimoto, S., Bekki, S., Kugiyama, Y., Kuno, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129053 · Cited by 81
A New Model of Interactive Effects of Alcohol and High-Fat Diet on Hepatic Fibrosis
Gäbele, E., Dostert, K., Dorn, C., Patsenker, E., Stickel, F., & Hellerbrand, C. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01472.x · Cited by 81
Metadata
- Authors
- Bataller, R., & Brenner, D. A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Brenner, David A.
- ORCID
- Brenner, David A.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-02-01
- Volume
- 115
- Issue
- 2
- Pages
- 209-218
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4255712601
- Cited by
- 4,958
- References
- 134
- Citations by year
- 2026: 177 · 2025: 236 · 2024: 285 · 2023: 289 · 2022: 307 · 2021: 321 · 2020: 294 · 2019: 275 · 2018: 284 · 2017: 295 · 2016: 281 · 2015: 307 · 2014: 229 · 2013: 224 · 2012: 222
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Ciencia y Tecnología
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver fibrosis, extracellular matrix accumulation, collagen deposition, chronic liver disease, liver cirrhosis, hepatic stellate cells, portal fibroblasts, myofibroblasts, TGF-β1, angiotensin II, leptin, fibrogenic cytokines, antifibrotic agents, fibrosis pathogenesis, fibrosis diagnosis, liver transplantation
- MeSH terms
- Angiotensin II, Animals, Humans, Hypertension, Portal, Liver Cirrhosis, Transforming Growth Factor beta, Liver Failure, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review